Veterinary Medicines

PORCILIS APP SUSPENSION INYECTABLE PARA PORCINO

Authorised
  • Actinobacillus pleuropneumoniae, serovar 1, strain APP 1-l-452, Outer membrane protein
  • Actinobacillus pleuropneumoniae, serovar 2, strain APP2, APX III toxoid
  • Actinobacillus pleuropneumoniae, serovar 2, strain App2, APX II toxoid and serovar 7, strain App HV143, APX II toxoid
  • Actinobacillus pleuropneumoniae, serovar 10, strain APP HV169, APX I toxoid
Download as PDF

Product identification

Medicine name:
PORCILIS APP SUSPENSION INYECTABLE PARA PORCINO
Active substance:
  • Actinobacillus pleuropneumoniae, serovar 1, strain APP 1-l-452, Outer membrane protein
  • Actinobacillus pleuropneumoniae, serovar 2, strain APP2, APX III toxoid
  • Actinobacillus pleuropneumoniae, serovar 2, strain App2, APX II toxoid and serovar 7, strain App HV143, APX II toxoid
  • Actinobacillus pleuropneumoniae, serovar 10, strain APP HV169, APX I toxoid
Target species:
  • Pig (weaned piglet)
Route of administration:
  • Intramuscular use

Product details

Active substance and strength:
  • Actinobacillus pleuropneumoniae, serovar 1, strain APP 1-l-452, Outer membrane protein
    10000.00
    Protective Dose
    /
    2.00
    millilitre(s)
  • Actinobacillus pleuropneumoniae, serovar 2, strain APP2, APX III toxoid
    10000.00
    Protective Dose
    /
    2.00
    millilitre(s)
  • Actinobacillus pleuropneumoniae, serovar 2, strain App2, APX II toxoid and serovar 7, strain App HV143, APX II toxoid
    500.00
    Protective Dose
    /
    2.00
    millilitre(s)
  • Actinobacillus pleuropneumoniae, serovar 10, strain APP HV169, APX I toxoid
    500.00
    Protective Dose
    /
    2.00
    millilitre(s)
Pharmaceutical form:
  • Suspension for injection
Withdrawal period by route of administration:
  • Intramuscular use
    • Pig (weaned piglet)
      • Meat and offal
        0
        day
Anatomical therapeutic chemical veterinary (ATCvet) codes:
  • QI09AB07
Legal status of supply:
  • Veterinary medicinal product subject to veterinary prescription
Authorisation status:
  • Valid
Authorised in:
  • Spain
Package description:

Additional information

Entitlement type:
  • Marketing Authorisation
Legal basis of product authorisation:
  • Full application - Known active substance (Article 12(3) of Directive No 2001/82/EC)
Marketing authorisation holder:
  • Merck Sharp & Dohme Animal Health S.L.
Marketing authorisation date:
Manufacturing sites for batch release:
  • Intervet International B.V.
Responsible authority:
  • Spanish Agency Of Medicines And Medical Devices
Authorisation number:
  • 3275 ESP
Date of authorisation status change:

Documents

Summary of Product Characteristics

This document does not exist in this language (English). You can find it in another language below.
Spanish (PDF)
Published on: 9/01/2025
Download

Package Leaflet

This document does not exist in this language (English). You can find it in another language below.
Spanish (PDF)
Published on: 9/01/2025
Download

Labelling

This document does not exist in this language (English). You can find it in another language below.
Spanish (PDF)
Published on: 9/01/2025
Download